UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 4, 2013

CAMBRIDGE HEART, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware		000-20991		13-3679946
(State or Other Jurisdiction of Incorporation		(Commission File Number)		(IRS Employer Identification No.)

100 Ames Pond Drive, Tewksbury, MA		01876
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: 978-654-7600

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective November 4, 2013, Roderick de Greef resigned from the Board of Directors of Cambridge Heart, Inc. (the “Company”). Prior to his resignation, Mr. de Greef was serving as Chairman of the Board of Directors of the Company and also as interim President and Treasurer of the Company, on an unpaid basis. Mr. de Greef did not resign over any disagreement with the Company’s Board of Directors or its management.

In addition, effective November 20, 2013 Ali Haghighi-Mood resigned from the Board of Directors of the Company. Mr. Haghighi-Mood did not resign over any disagreement with the Company’s Board of Directors or its management.

Item 8.01. Other Events.

As of November 6, 2013, 100,112,960 shares of the Company’s common stock were outstanding. On an as-converted basis, the Company has 124,659,416 shares of common stock issued and outstanding, including 100,112,960 shares of common stock issued, 4,180,602 shares issuable upon conversion of the Series C-1 Convertible Preferred Stock and 20,365,854 shares issuable upon conversion of the Series D Convertible Preferred Stock.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CAMBRIDGE HEART, INC.

Date: November 26, 2013	By:	/s/ Paul McCormick
		Paul McCormick
		Director

CAMBRIDGE HEART INC 8-K